The effect of hormone-modulating therapy during pregravid preparation on the course of pregnancy and childbirth in patients with a history of endometriosis

Abstract

BACKGROUND: Endometriosis is a benign proliferation of tissue similar in morphological and functional characteristics with endometrium outside the uterine. In the structure of gynecological diseases, it ranks on the third place and its prevalence is growing steadily every year.

AIM: The aim of this study was to analyze the features of pregnancy and childbirth in patients with endometriosis who received hormone-modulating therapy during pregravid preparation.

MATERIALS AND METHODS: This retrospective analysis of the course of pregnancy and childbirth in patients with a surgically confirmed diagnosis of varying severity endometriosis (n = 140) in history was carried out at the Center for Diagnosis and Treatment of Endometriosis, The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott, Saint Petersburg, Russia. The control group consisted of pregnant women without endometriosis (n = 50).

RESULTS: Before pregnancy, 82.1% (n = 115) of patients with endometriosis used hormone-modulating therapy, while 17.9% (n = 15) of patients did not comply with the given therapy. During therapy, 70% (n = 98) of patients mentioned decreasing in the severity of pain. In patients with a history of endometriosis, threatened miscarriage took the leading place and was identified in 24.3% of cases in the first and second trimesters and in 33.6% of cases in the third trimester of pregnancy, which was consistently higher than in the control group. Miscarriage was observed in 38.5% of patients and recurrent pregnancy loss in 18.6% of women. Preeclampsia was diagnosed in 23.8% (n = 33) of patients with endometriosis. The use of hormone-modulating therapy during pregravid preparation was shown to reduce the risk of developing preeclampsia among patients with endometriosis by 4.1 times, and the use of dienogest 2 mg as the therapy of endometriosis to reduce the frequency of preeclampsia by ten times in comparison with patients who did not receive any treatment. Fetal growth restriction was observed in 18.6% (n = 26) of patients with endometriosis. The presence of endometriosis increased the likelihood of developing fetal growth restriction by 3.6 times and reduced the likelihood of having a large fetus by 2.7 times. Preterm birth was observed in 20% (n = 28) of patients with endometriosis, which is four times higher than in the control group (p = 0.019). Most pregnant women with a history of endometriosis – 64.3 % (n = 90) of patients – were delivered by cesarean section, while 35.7% (n = 50) of women had vaginal birth, which was 3.34 times higher than the frequency of cesarean section in the control group.

CONCLUSIONS: Patients with a history of endometriosis are at high risk for the development of obstetric complications associated with the pathogenesis of the disease. An integrated approach to the treatment of endometriosis with the use of hormone-modulating therapy during pregravid preparation and personalized management of patients in different trimesters of pregnancy can reduce the risk of complications of pregnancy and childbirth.

Keywords

endometriosis / pregnancy / preterm birth / premature placental abruption / assisted reproductive technology

References

[1] Tomassetti C, Bafort C, Meuleman C, et al. Reproducibility of the Endometriosis Fertility Index: a prospective inter-/intra-rater agreement study. BJOG. 2020;127(1):107–114. DOI: 10.1111/1471-0528.15880

[2] Tomassetti C., Bafort C., Meuleman C., et al. Reproducibility of the endometriosis fertility index: a prospective inter-/intra-rater agreement study // BJOG. 2020. Vol. 127. No. 1. P. 107–114. DOI: 10.1111/1471-0528.15880

[3] Endometrioz. Klinicheskie rekomendatsii. Rossiyskoe obshchestvo akusherov-ginekologov. 2020. (In Russ.) [cited 2023 Oct 24]. Available from: https://roag-portal.ru/recommendations_gynecology#pdfcontent_gin_3

[4] Эндометриоз. Клинические рекомендации. Российское общество акушеров-гинекологов. 2020 [дата обращения 24.10.2023]. Доступ по ссылке: https://roag-portal.ru/recommendations_gynecology#pdfcontent_gin_3

[5] Yarmolinskaya MI, Denisova VM. Importance of genital endometriosis in pathogenesis of infertility. Journal of Obstetrics and Women’s Diseases. 2013;62(6):67–77. (In Russ.) DOI: 10.17816/JOWD62667-77

[6] Ярмолинская М.И., Денисова В.М. Значение генитального эндометриоза в патогенезе бесплодия // Журнал акушерства и женских болезней. 2013. Т. 62. № 6. C. 67–77. DOI: 10.17816/JOWD62667-77

[7] As-Sanie S, Black R, Giudice LC, et al. Assessing research gaps and unmet needs in endometriosis. Am J Obstet Gynecol. 2019;221(2):86–94. DOI: 10.1016/j.ajog.2019.02.033

[8] As-Sanie S., Black R., Giudice L.C., et al. Assessing research gaps and unmet needs in endometriosis // Am. J. Obstet. Gynecol. 2019. Vol. 221. No. 2. P. 86–94. DOI: 10.1016/j.ajog.2019.02.033

[9] Koninckx PR, Zupi E, Martin DC. Endometriosis and pregnancy outcome. Fertil Steril. 2018;110(3):406–407. DOI: 10.1016/j.fertnstert.2018.06.029

[10] Koninckx P.R., Zupi E., Martin D.C. Endometriosis and pregnancy outcome // Fertil. Steril. 2018. Vol. 110. No. 3. P. 406–407. DOI: 10.1016/j.fertnstert.2018.06.029

[11] Janowitz L, Cooper-Mercado R, Soto M. Endometriosis in pregnancy: a case report. Cureus. 2022;14(9). DOI: 10.7759/cureus.28749

[12] Janowitz L., Cooper-Mercado R., Soto M. Endometriosis in pregnancy: a case report // Cureus. 2022. Vol. 14. No. 9. DOI: 10.7759/cureus.28749

[13] Zullo F, Spagnolo E, Saccone G, et al. Endometriosis and obstetrics complications: a systematic review and meta-analysis. Fertil Steril. 2017;108(4):667–672. DOI: 10.1016/j.fertnstert.2017.07.019

[14] Zullo F., Spagnolo E., Saccone G., et al. Endometriosis and obstetrics complications: a systematic review and meta- analysis // Fertil. Steril. 2017. Vol. 108. No. 4. P. 667–672. DOI: 10.1016/j.fertnstert.2017.07.019

[15] Alberico D, Somigliana E, Bracco B, et al. Potential benefits of pregnancy on endometriosis symptoms. Eur J Obstet Gynecol Reprod Biol. 2018;230:182–187. DOI: 10.1016/j.ejogrb.2018.08.576

[16] Alberico D., Somigliana E., Bracco B., et al. Potential benefits of pregnancy on endometriosis symptoms // Eur. J. Obstet. Gynecol. Reprod. Biol. 2018. Vol. 230. P. 182–187. DOI: 10.1016/j.ejogrb.2018.08.576

[17] Günther V, Allahqoli L, Gitas G, et al. Impact of adenomyosis on infertile patients-therapy options and reproductive outcomes. Biomedicines. 2022;10(12):3245. DOI: 10.3390/biomedicines10123245

[18] Günther V., Allahqoli L., Gitas G., et al. Impact of adeno myosis on infertile patients-therapy options and reproductive outcomes // Biomedicines. 2022. Vol. 10. No. 12. P. 3245. DOI: 10.3390/biomedicines10123245

[19] Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online. 2021;42(1):185–206. DOI: 10.1016/j.rbmo.2020.09.023

[20] Nirgianakis K., Kalaitzopoulos D.R., Schwartz A.S.K., et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis // Reprod. Biomed. Online. 2021. Vol. 42. No. 1. P. 185–206. DOI: 10.1016/j.rbmo.2020.09.023

[21] Alkatout İ, Meinhold-Heerlein I, Keckstein J, et al. Endometriosis: a concise practical guide to current diagnosis and treatment. J Turk Ger Gynecol Assoc. 2018;19(3):173–175. DOI: 10.4274/jtgga.2018.0026

[22] Alkatout İ., Meinhold-Heerlein I., Keckstein J., et al. Endometriosis: a concise practical guide to current diagnosis and treatment // J. Turk. Ger. Gynecol. Assoc. 2018. Vol. 19. No. 3. P. 173–175. DOI: 10.4274/jtgga.2018.0026

[23] Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endomet riosis. Hum Reprod Open. 2022;2022(2). DOI: 10.1093/hropen/hoac009

[24] Becker C.M., Bokor A., Heikinheimo O., et al. ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis // Hum. Reprod. Open. 2022. Vol. 2022. No. 2. DOI: 10.1093/hropen/hoac009

[25] Yarmolinskaya MI, Rusina EI, Semenova VO, et al. Extragenital endometriosis: diagnostic difficulties, modern treatment policy. Obstetrics and Gynecology. 2022;(8):154–162. DOI: 10.18565/aig.2022.8.154-162

[26] Ярмолинская М.И., Русина Е.И., Семенова В.О., и др. Экстрагенитальный эндометриоз: сложности диагностики, современная тактика лечения // Акушерство и гинекология. 2022. № 8. С. 154–162. DOI: 10.18565/aig.2022.8.154-162

[27] Liu Y, Zhang W. Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget. 2017;8(29):46928–46936. DOI: 10.18632/oncotarget.14916

[28] Yong L., Weiyuan Z. Association between body mass index and endometriosis risk: a meta-analysis // Oncotarget. 2017. Vol. 8. No. 29. P. 46928–46936. DOI: 10.18632/oncotarget.14916

[29] Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175–184. DOI: 10.1172/JCI29881

[30] Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization // J. Clin. Invest. 2007. Vol. 117. No. 1. P. 175–184. DOI: 10.1172/JCI29881

[31] Pantelis A, Machairiotis N, Lapatsanis DP. The Formidable yet Unresolved Interplay between Endometriosis and Obesity. ScientificWorldJournal. 2021;2021. DOI: 10.1155/2021/6653677

[32] Pantelis A., Machairiotis N., Lapatsanis D.P. The formidable yet unresolved interplay between endometriosis and obesity // ScientificWorldJournal. 2021. Vol. 2021. DOI: 10.1155/2021/6653677

[33] Cohen Ben-Meir L, Soriano D, Zajicek M, et al. The association between gastrointestinal symptoms and transvaginal ultrasound findings in women referred for endometriosis evaluation: a prospective pilot study. Ultraschall Med. 2022;43(5):e81–e89. DOI: 10.1055/a-1300-1887

[34] Cohen Ben-Meir L., Soriano D., Zajicek M., et al. The association between gastrointestinal symptoms and transvaginal ultrasound findings in women referred for endometriosis evaluation: a prospective pilot study // Ultraschall Med. 2022. Vol. 43. No. 5. P. e81–e89. DOI: 10.1055/a-1300-1887

[35] Yarmolinskaya MI, Beganova AK, Revenko AS. Endometriosis-associated pain and new therapeutic options: a review. Gynecology. 2023;24(6):444–450. DOI: 10.26442/20795696.2022.6.201975

[36] Ярмолинская М.И., Беганова А.К., Ревенко А.С. Эндомет риоз-ассоциированный болевой синдром и новые возможности терапии // Гинекология. 2022. Т. 24. № 6. С. 444–450. DOI: 10.26442/20795696.2022.6.201975

[37] Tamari M, Ver Heul AM, Kim BS. Immunosensation: neuroimmune cross talk in the skin. Annu Rev Immunol. 2021;39:369–393. DOI: 10.1146/annurev-immunol-101719-113805

[38] Tamari M., Ver Heul A.M., Kim B.S. Immunosensation: neuroimmune cross talk in the skin // Ann. Rev. Immunol. 2021. Vol. 39. P. 369–393. DOI: 10.1146/annurev-immunol-101719-113805

[39] Gao D, Gao X, Yang F, et al. Neuroimmune crosstalk in rheumatoid arthritis. Int J Mol Sci. 2022;23(15). DOI: 10.3390/ijms23158158

[40] Gao D., Gao X., Yang F., et al. Neuroimmune crosstalk in rheumatoid arthritis // Int. J. Mol. Sci. 2022. Vol. 23. No. 15. DOI: 10.3390/ijms23158158

[41] Gimenes C, Bianco B, Mafra FA, et al. The progins progesterone receptor gene polymorphism is not related to endometriosis-associated infertility or to idiopathic infertility. Clinics (Sao Paulo). 2010;65(11):1073–1076. DOI: 10.1590/s1807-59322010001100002

[42] Gimenes C., Bianco B., Mafra F.A., et al. The progins progesterone receptor gene polymorphism is not related to endometriosis-associated infertility or to idiopathic infertility // Clinics (Sao Paulo). 2010. Vol. 65. No. 11. P. 1073–1076. DOI: 10.1590/s1807-59322010001100002

[43] Barbara G, Facchin F, Buggio L, et al. What is known and unknown about the association between endometriosis and sexual functioning: a systematic review of the literature. Reprod Sci. 2017;24(12):1566–1576. DOI: 10.1177/1933719117707054

[44] Barbara G., Facchin F., Buggio L., et al. What is known and unknown about the association between endometriosis and sexual functioning: a systematic review of the literature // Reprod. Sci. 2017. Vol. 24. P. 1566–1576. DOI: 10.1177/1933719117707054

[45] Pluchino N, Wenger JM, Petignat P, et al. Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment. Hum Reprod Update. 2016;22(6):762–774. DOI: 10.1093/humupd/dmw031

[46] Pluchino N., Wenger J.M., Petignat P., et al. Sexual function in endometriosis patients and their partners: Effect of the disease and consequences of treatment // Hum. Reprod. Update. 2016. Vol. 22. P. 762–774. DOI: 10.1093/humupd/dmw031

[47] Mehasseb MK, Panchal R, Taylor AH, et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril. 2011;95(7):2228–2235.e1. DOI: 10.1016/j.fertnstert.2011.02.051

[48] Mehasseb M.K., Panchal R., Taylor A.H., et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis // Fertil. Steril. 2011. Vol. 95. No. 7. P. 2228–2235. DOI: 10.1016/j.fertnstert.2011.02.051

[49] Karita M, Yamashita Y, Hayashi A, et al. Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells? Fertil Steril. 2011;95(3):889–894. DOI: 10.1016/j.fertnstert.2010.12.026

[50] Karita M., Yamashita Y., Hayashi A., et al. Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells? // Fertil. Steril. 2011. Vol. 95. No. 3. P. 889–894. DOI: 10.1016/j.fertnstert.2010.12.026

[51] Aghajanova L, Giudice LC. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci. 2011;18(3):229–251. DOI: 10.1177/1933719110386241

[52] Aghajanova L., Giudice L.C. Molecular evidence for differences in endometrium in severe versus mild endometriosis // Reprod. Sci. 2011. Vol. 18. No. 3. P. 229–251. DOI: 10.1177/1933719110386241

[53] Lysenko BM. Features of pathogenesis of combination of a genital endometriosis and hypothyrosis. Health of Woman. 2016;9(115):75–77. DOI: 10.15574/HW.2016.115.75

[54] Лысенко Б.М. Особенности патогенеза сочетания генитального эндометриоза и гипотиреоза // Здоровье женщины. 2016. № 9(115). С. 75–77. DOI: 10.15574/HW.2016.115.75

[55] Lima AP, Moura MD, Rosa e Silva AA. Prolactin and cortisol levels in women with endometriosis. Braz J Med Biol Res. 2006;39(8):1121–1127. DOI: 10.1590/s0100-879x2006000800015

[56] Lima A.P., Moura M.D., Rosa e Silva A.A. Prolactin and cortisol levels in women with endometriosis // Braz. J. Med. Biol. Res. 2006. Vol. 39. No. 8. P. 1121–1127. DOI: 10.1590/s0100-879x2006000800015

[57] Tai FW, Chang CY, Chiang JH, et al. Association of pelvic inflammatory disease with risk of endometriosis: a nationwide cohort study involving 141,460 individuals. J Clin Med. 2018;7(11):379. DOI: 10.3390/jcm7110379

[58] Tai F.W., Chang C.Y., Chiang J.H. et al. Association of pelvic inflammatory disease with risk of endometriosis: a nationwide cohort study involving 141,460 individuals // J. Clin. Med. 2018. Vol. 7. No. 11. P. 379. DOI: 10.3390/jcm7110379

[59] Kimura F, Takebayashi A, Ishida M, et al. Review: chronic endometritis and its effect on reproduction. J Obstet Gynaecol Res. 2019;45(5):951–960. DOI: 10.1111/jog.13937

[60] Kimura F., Takebayashi A., Ishida M., et al. Review: chronic endometritis and its effect on reproduction // J. Obstet. Gynaecol. Res. 2019. Vol. 45. No. 5. P. 951–960. DOI: 10.1111/jog.13937

[61] Vannuccini S, Clifton VL, Fraser IS, et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2016;22(1):104–115. DOI: 10.1093/humupd/dmv044

[62] Vannuccini S., Clifton V.L., Fraser I.S., et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome // Hum. Reprod. Update. 2016. Vol. 22. No. 1. P. 104–115. DOI: 10.1093/humupd/dmv044

[63] Porpora MG, Tomao F, Ticino A, et al. Endometriosis and pregnancy: a single institution experience. Int J Environ Res Public Health. 2020;17(2):401. DOI: 10.3390/ijerph17020401

[64] Porpora M.G., Tomao F., Ticino A., et al. Endometriosis and pregnancy: a single institution experience // Int. J. Environ. Res. Public. Health. 2020. Vol. 17. No. 2. P. 401. DOI: 10.3390/ijerph17020401

[65] Yarmolinskaya M.I. Genital’nyy endometrioz: vliyanie gor monal’nykh, immunologicheskikh i geneticheskikh faktorov na razvitie, osobennosti techeniya i vybor terapii [dissertation]. Saint Petersburg; 2009. (In Russ.) [cited 2023 Sept 12]. Available from: https://www.dissercat.com/content/genitalnyi-endometrioz-vliyanie-gormonalnykh-immunologicheskikh-i-geneticheskikh-faktorov-na

[66] Ярмолинская М.И. Генитальный эндометриоз: влияние гормональных, иммунологических и генетических факторов на развитие, особенности течения и выбор терапии: диc. ... д-ра мед. наук. Санкт-Петербург, 2009 [дата обращения 12.09.2023]. Доступ по ссылке: https://www.dissercat.com/content/genitalnyi-endometrioz-vliyanie-gormonalnykh-immunologicheskikh-i-geneticheskikh-faktorov-na

[67] Farland LV, Prescott J, Sasamoto N, et al. Endometriosis and risk of adverse pregnancy outcomes. Obstet Gynecol. 2019;134(3):527–536. DOI: 10.1097/AOG.0000000000003410

[68] Farland L.V., Prescott J., Sasamoto N., et al. Endometriosis and risk of adverse pregnancy outcomes // Obstet. Gynecol. 2019. Vol. 134. No. 3. P. 527–536. DOI: 10.1097/AOG.0000000000003410

[69] DoPierala AL, Bhatta S, Raja EA, et al. Obstetric consequences of subfertility: a retrospective cohort study. BJOG. 2016;123(8):1320–1328. DOI: 10.1111/1471-0528.13584

[70] DoPierala A.L., Bhatta S., Raja E.A., et al. Obstetric consequences of subfertility: a retrospective cohort study // BJOG. 2016. Vol. 123. No. 8. P. 1320–1328. DOI: 10.1111/1471-0528.13584

[71] Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med. 2012;18(12):1754–1767. DOI: 10.1038/nm.3012

[72] Cha J., Sun X., Dey S.K. Mechanisms of implantation: strategies for successful pregnancy // Nat. Med. 2012. Vol. 18. No. 12. P. 1754–1767. DOI: 10.1038/nm.3012

[73] Miura M, Ushida T, Imai K, et al. Adverse effects of endometriosis on pregnancy: a case-control study. BMC Pregnancy Childbirth. 2019;19(1):373. DOI: 10.1186/s12884-019-2514-1

[74] Miura M., Ushida T., Imai K., et al. Adverse effects of endometriosis on pregnancy: a case-control study // BMC Pregnancy Childbirth. 2019. Vol. 19. No. 1. P. 373. DOI: 10.1186/s12884-019-2514-1

[75] Uccella S, Manzoni P, Cromi A, et al. Pregnancy after endometriosis: maternal and neonatal outcomes according to the location of the disease. Am J Perinatol. 2019;36(2):S91–S98. DOI: 10.1055/s-0039-1692130

[76] Uccella S., Manzoni P., Cromi A., et al. Pregnancy after endomet riosis: maternal and neonatal outcomes according to the location of the disease // Am. J. Perinatol. 2019. Vol. 36. No. 2. P. S91–S98. DOI: 10.1055/s-0039-1692130

RIGHTS & PERMISSIONS

Eсо-Vector